Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes - Report - MDSpire

Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes

  • By

  • Olaf Schoffer

  • Max Kemper

  • Michael Gerken

  • Veronika Bierbaum

  • Christoph Bobeth

  • Martin Rößler

  • Patrik Dröge

  • Thomas Ruhnke

  • Christian Günster

  • Kees Kleihues-van Tol

  • Chia-Jung Busch

  • Monika Klinkhammer-Schalke

  • Jochen Schmitt

  • January 26, 2026

  • 0 min

Share

Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes

Overview

This study evaluates whether treatment in German Cancer Society (DKG)-certified head and neck cancer centers improves patient survival compared to non-certified facilities. Using nationwide health insurance and cancer registry data from 2009 to 2017, the analysis investigates survival outcomes across certified and non-certified centers.

Background

Head and neck cancers are a heterogeneous group of malignancies with significant morbidity and mortality, with approximately 21.8 new cases per 100,000 people in Europe annually. Survival rates vary widely by tumor location and stage, underscoring the need for high-quality, multidisciplinary care. In Germany, certification programs by the DKG aim to standardize and improve cancer care quality through stringent requirements and quality indicators. This study explores whether such certification correlates with improved survival outcomes for head and neck cancer patients.

Data Highlights

The WiZen cohort study utilized anonymized statutory health insurance data from AOK and clinical cancer registry data from four German regions, covering diagnoses from 2009 to 2017. Structural hospital data and DKG certification status were integrated to compare survival outcomes between certified and non-certified centers. The dataset included multiple cancer types, with a focus here on head and neck cancers.

Key Findings

  • Certification by the German Cancer Society requires comprehensive adherence to guidelines and minimum treatment volumes, ensuring multidisciplinary care.
  • Approximately 55.27% of head and neck cancer cases in Germany in 2023 were treated in DKG-certified facilities.
  • Survival rates for head and neck cancers vary significantly by tumor site and stage, highlighting the importance of specialized care.
  • Previous studies in other cancer types have demonstrated improved survival associated with treatment in certified centers.
  • The WiZen study provides evidence supporting the positive impact of certification on survival outcomes in head and neck cancer patients.

Clinical Implications

Clinicians should consider referring head and neck cancer patients to DKG-certified centers to benefit from multidisciplinary expertise and adherence to evidence-based guidelines. Certification ensures access to comprehensive treatment modalities and may improve survival outcomes. Healthcare systems should support certification processes to enhance care quality and patient prognosis.

Conclusion

Treatment in DKG-certified head and neck cancer centers is associated with improved survival outcomes, justifying the efforts and resources invested in certification. These findings support ongoing initiatives to promote certification and multidisciplinary care in oncology.

Related Resources & Content

  1. Schmitt et al. 2023 -- Effectiveness of care in certified cancer centers (WiZen study)
  2. German Cancer Society (DKG) -- Certification Programs and Guidelines
  3. European Cancer Registry -- Head and Neck Cancer Incidence and Mortality

Original Source(s)

Related Content